Advertisement
UK markets close in 4 hours 9 minutes
  • FTSE 100

    8,118.94
    +40.08 (+0.50%)
     
  • FTSE 250

    19,816.33
    +214.35 (+1.09%)
     
  • AIM

    755.56
    +2.44 (+0.32%)
     
  • GBP/EUR

    1.1661
    +0.0004 (+0.04%)
     
  • GBP/USD

    1.2518
    +0.0007 (+0.05%)
     
  • Bitcoin GBP

    51,288.17
    +363.30 (+0.71%)
     
  • CMC Crypto 200

    1,383.62
    -12.91 (-0.92%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.11
    +0.54 (+0.65%)
     
  • GOLD FUTURES

    2,359.60
    +17.10 (+0.73%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,059.48
    +142.20 (+0.79%)
     
  • CAC 40

    8,042.45
    +25.80 (+0.32%)
     

Glaxo Pops But Analysts Say It's Unlikely To Swipe Gilead Share In HIV

Glaxo Pops But Analysts Say It's Unlikely To Swipe Gilead Share In HIV

GlaxoSmithKline popped Thursday after its two-drug HIV treatment proved non-inferior to a three-drug regimen using medicine from Gilead Sciences. But analysts say Glaxo is unlikely to get much share from Gilead.